Aaron Levitt

InvestorPlace Contributor

Aaron Levitt is an independent investment analyst and author living in State College, Pennsylvania. His work appears in several high profile publications in both print and on the web.

As an advocate for long-term globally oriented investing, Aaron believes that exchange traded funds have leveled playing field for Main Street. Following global macro-economic trends, investors now have several avenues to create great long term portfolios.

Aaron is a graduate of The Pennsylvania State University where he studied Economics and International Business. Aside for helping regular investors develop winning portfolios, his current projects include writing his first book on alternative energy investing.

Follow his picks and pans on Twitter at @AaronLevitt.

Recent Articles

5 Energy Stocks Coming Back From the Dead

By Aaron Levitt, InvestorPlace Contributor Jan 25, 2018

Thanks to rising energy prices, these 5 stocks are coming back from the dead. They have a lot to gain from the current rise in crude.

Don’t Follow Icahn Into Xerox

By Aaron Levitt, InvestorPlace Contributor Jan 24, 2018

Carl Icahn's moves into XRX may not produce the desired results. Investors may want to stay away from Xerox for now.

Why Celgene Corporation Stock Is ALL About the Buyouts

By Aaron Levitt, InvestorPlace Contributor Jan 22, 2018

For CELG stock, traders are going focus on its pipeline and nothing else. With that in mind, here's what Celgene's longer-term prospects look like.

Pandora Media Inc Stock Could Get a Buyout Boost

By Aaron Levitt, InvestorPlace Contributor Jan 22, 2018

Pandora is struggling and that could be a good thing. In the end, P stock is a great buyout candidate.

5 Big Biotech Stocks To Buy In 2018

By Aaron Levitt, InvestorPlace Contributor Jan 17, 2018

Biotech stocks had a great run in 2017. The new year could have more big gains ahead. Here are 5 top biotech stocks to buy today.